Huidagene Therapeutics

Shanghai, China · Founded 2018 · Privately Held (backing)

Developer of gene therapy drugs designed for the treatments of rare human genetic diseases. Huidagene Therapeutics is based in Shanghai, China and was founded in 2018. It has raised $80.4 million.

Last price · $/share
—
Implied valuation
—
Total raised
$80.4M
Last round
—

Who backs Huidagene Therapeutics?

7 investors
InvestorType
GL VenturesVenture capital
Beijing Ruiyin Weiye Technology DevelopmentGrowth equity
HM Capital—
HM Venture Partners—
Kunnuo Tianqin Venture Capital—
Sherpa Healthcare Partners—
WuXi AppTec—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Huidagene Therapeutics investors

7 investors are on record for Huidagene Therapeutics, including GL Ventures, Beijing Ruiyin Weiye Technology Development, HM Capital and HM Venture Partners.

Free account
More of Huidagene Therapeutics with a free account
  • ·Watch Huidagene Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like Huidagene Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View